The choice between PCV13 and PPSV23 depends on various factors, including the patient's age, health status, and vaccination history. Generally, it is recommended that cancer patients receive both vaccines:
PCV13: Usually given first. PPSV23: Administered at least 8 weeks after PCV13.
Some patients may require additional doses or boosters, especially if they have ongoing immunosuppression.
